Literature DB >> 7881834

The management of systemic sclerosis.

C M Black, C P Denton.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7881834     DOI： 10.1093/rheumatology/34.1.3

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN： 0263-7103


× No keyword cloud information.
  4 in total

1.  European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.

Authors:  A Della Rossa; G Valentini; S Bombardieri; W Bencivelli; A J Silman; S D'Angelo; M M Cerinic; J F Belch; C M Black; R Becvar; P Bruhlman; F Cozzi; L Czirják; A A Drosos; B Dziankowska; C Ferri; A Gabrielli; R Giacomelli; G Hayem; M Inanc; N J McHugh; H Nielsen; R Scorza; E Tirri; F H van den Hoogen; P G Vlachoyiannopoulos
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  How can treatment of systemic sclerosis be improved?. By setting up a national database of all cases and entering patients into trials. UK Scleroderma Study Group.

Authors: 
Journal:  BMJ       Date:  1998-08-01

Review 3.  Drug treatment of scleroderma.

Authors:  C Leighton
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis.

Authors:  Adam Doré; Mary Lucas; Dana Ivanco; Thomas A Medsger; Robyn T Domsic
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.